Health
Nanoparticles elicit neutralizing antibodies to diverse SARS-CoV-2 variants – News-Medical.net
Spike-protein-based nanoparticle vaccine candidates were retained longer in follicular dendritic cells and showed higher germinal center reactions in lymph node…
Spike-protein-based nanoparticle vaccine candidates were retained longer in follicular dendritic cells and showed higher germinal center reactions in lymph node follicles compared to soluble spike protein vaccine.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected hundreds of millions worldwide since its emergence more than a year ago. The virus has also been mutating throughout the pandemic, with several new variants, likely more infectious, being reported over the last…
-
Noosa News23 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General24 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General15 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News12 hours agoAlternative pathways to university explained